Boston Scientific, founded in 2008, is a global leader in the health care industry. The company is dedicated to transforming lives through innovative medical technologies, addressing unmet patient needs and reducing the cost of health care. With a diversified portfolio of devices and therapies, Boston Scientific focuses on complex cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions. Their last investment, a $25.00M Series C round, took place on 03 December 2013, with participation from prominent investors including Aperture Venture Partners, Third Point Ventures, Ascent Biomedical Ventures, Charter Life Sciences, and Prism Venture Management. The company's headquarters is located in the United States. With a strong track record and a focus on innovation, Boston Scientific presents itself as an attractive investment opportunity in the health care sector. For more information, visit www.bostonscientific.com and connect with them on various social media platforms.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | €2.00B | - | 22 Feb 2024 | |
| Post-IPO Debt | €3.00B | - | 04 Mar 2022 | |
| Post-IPO Equity | $2.00B | - | 21 May 2020 | |
| Post-IPO Debt | $1.00B | - | 27 Feb 2018 |
No recent news or press coverage available for Boston Scientific.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
